No headlines found.
No press releases found.
No news found.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Neuroone Medical Technologies trades on the NASDAQ stock market under the symbol NMTC.
As of June 10, 2026, NMTC stock price declined to $3.32 with 26,470 million shares trading.
NMTC has a beta of 0.85, meaning it tends to be less sensitive to market movements. NMTC has a correlation of 0.03 to the broad based SPY ETF.
NMTC has a market cap of $28.62 million. This is considered a Sub-Micro Cap stock.
Last quarter Neuroone Medical Technologies reported $2 million in Revenue and -$.25 earnings per share. This fell short of revenue expectation by $-185,330 and missed earnings estimates by -$.02.
In the last 3 years, NMTC traded as high as $12.00 and as low as $2.37.
The top ETF exchange traded funds that NMTC belongs to (by Net Assets): VTI, VXF.
NMTC has underperformed the market in the last year with a price return of -6.1% while the SPY ETF gained +22.2%. NMTC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.8% and -14.2%, respectively, while the SPY returned +7.2% and -3.4%, respectively.
NMTC support price is $3.20 and resistance is $3.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NMTC shares will trade within this expected range on the day.
